Top Industry Leaders in the Balantidiasis Market
Jan 2024Pfizer Conducted research on the efficacy and safety of their broad-spectrum antibiotic, Albendazole, for treating Balantidiasis.Partnered with research institutions in endemic regions to improve diagnosis and treatment protocols for balantidiasis.
Abbott Laboratories Collaborated with the CDC on a project to develop rapid diagnostic tests for balantidiasis, aiming for faster and more accurate diagnosis in resource-limited settings.Invested in research on alternative treatment options for balantidiasis, exploring the potential of herbal remedies and natural compounds.
World Health Organization (WHO) Updated their guidelines on the management of balantidiasis, emphasizing early diagnosis, effective treatment, and preventive measures like improved sanitation and hygiene practices.Provided technical assistance to countries with high balantidiasis burden to strengthen their healthcare systems and implement control strategies.
List of Balantidiasis Key Companies in the Market
- Pfizer (U.S.)
- Abbott (U.S.)
- GlaxoSmithKline plc. (U.K)
- BD (U.S.)
- Sandoz International GmbH (Germany)
- Amneal Pharmaceuticals LLC. (U.S.)
- Akorn, Inc. (U.S.)
- PharmaDerm, a division of Fougera Pharmaceuticals Inc. (U.S.)